IGC Pharma 10-K 03-31-25 - IGC Pharma, INC.

Proxy

Materials

August 19, 2025

IGC Pharma 10-K 03-31-25

IGC Pharma, Inc. IGC on NYSE

Related Posts

IGC Pharma, Inc. 424B5 As Filed

January 6, 2026

IGC Pharma, Inc. Form S-3A 12-3-25

December 3, 2025

IGC Pharma, Inc. Form S-3 11-14-25

November 14, 2025

CEO Update

igc pharma

IGC Pharma, Inc. 424B5 As Filed

January 6, 2026

IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability

January 6, 2026